
Therapeutic Segment
Resistant hypertension
CAS No.
1103522-45-7
Regulatory Filing
-
Development Status
Under development
Molecule Type
Small Molecule
Mechanism of Action
Dual endothelin receptor antagonist, which inhibits the binding of ET-1 to ETA and ETB receptors.